Trademarks Filed by SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA

4 trademark applications recorded in the national registry under this applicant name.

The IP India register records 4 trademark applications filed by SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA. The single filing on record is dated 28 October 2019. The portfolio is concentrated in Class 5 — Pharmaceuticals, which accounts for 100.0% of the filings. The most common registry status across the portfolio is DRAFT (4 marks).

4Applications
1Classes covered
Oct 2019First filing
Oct 2019Latest filing

Classes SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA Has Filed In

NICE classes ranked by applications filed under this name. Indian trademark protection extends only to the classes actually filed in — a class absent from this table is not covered by these registrations.
NICE classShare of portfolioApplications
Class 5 — Pharmaceuticals4 (100%)

Registry Status of These Filings

Status is the free-text value the registry records against each application. "Unknown" means no status had been published for that record at the last refresh.
StatusShare of portfolioApplications
DRAFT4 (100%)

All Trademarks Filed by SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA

Every trademark application the register attributes to SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA, newest filing first. Each row links to that mark's full registry record.

  1. DAUNOREM
    App. No. 4332697Class 5Filed 28 Oct 2019
    DRAFT
  2. LEUCOREM
    App. No. 4332696Class 5Filed 28 Oct 2019
    DRAFT
  3. REMIFLUCOX
    App. No. 4332695Class 5Filed 28 Oct 2019
    DRAFT
  4. REMILUSE
    App. No. 4332694Class 5Filed 28 Oct 2019
    DRAFT

About this data

Source
Sourced from the official IP India trademark register and the Trade Marks Journal. Only records published by the registry are counted — never applications filed through Trademarx.
Grouped by
The applicant name recorded on each application, normalised for case, spacing and punctuation — so "SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA" and its other recorded spellings appear together on this page.
Refreshed
Hourly.
Known limitation
Marks a business holds under a group company, a subsidiary, or a founder's personal name are recorded against those names and appear on their own pages, not here.

Frequently asked questions

How many trademarks does SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA have?

4 trademark applications in the IP India register are filed under the name SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA. This counts filings recorded against that applicant name; marks held under a group company, a subsidiary, or a founder's personal name are recorded separately.

Which trademark classes does SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA file in?

Class 5 — Pharmaceuticals is the most-used class, with 4 filings — 100.0% of the portfolio. In total the portfolio covers 1 NICE class. Indian trademark protection only extends to the classes actually filed in, so classes absent from this list are not covered by these registrations.

Can I use a brand name similar to one filed by SUREKHA S GUPTA (PROPRIETOR) TRADING AS REMEDY PHARMA?

Not safely, if it is in a class this applicant already covers. A mark that is identical or deceptively similar to an earlier filing in the same or a related class can be refused by the registry or opposed after publication. Run a clearance search across the relevant classes before adopting a name.

How current is this data?

Sourced from the official IP India trademark register and the Trade Marks Journal. Only records published by the registry are counted — never applications filed through Trademarx. Status and class shown reflect what the Registry has on file at the time of the most recent refresh.

Checking a competitor, a partner, or your own portfolio?

Free clearance search, IP India authorised agents, filing from ₹1,499 + govt. fees.

Data sourced from the official IP India trademark registry and Trade Marks Journal, refreshed continuously. Search another company →